P53 long noncoding RNA regulatory network in cancer development

Surendar Aravindhan1, Laith A Younus2, Methaq Hadi Lafta3

  • 1Department of Pharmacology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, chennai, India.

Insights

The tumor suppressor protein p53 and long noncoding RNAs (lncRNAs) interact to regulate gene expression, impacting cell cycle and apoptosis in cancer. Understanding this crosstalk is crucial for cancer therapy development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • The protein p53 functions as a transcription factor with significant tumor-suppressive activities, crucial for DNA damage recognition, repair, and apoptosis.
  • Alterations in p53 are common in human malignancies, and its pathway deregulation drives carcinogenesis and tumor progression.
  • The role of p53 in regulating long noncoding RNAs (lncRNAs) and their impact on cancer biology is increasingly recognized.

Purpose of the Study:

  • To review the intricate relationship between p53 pathways and lncRNAs in cancer.
  • To elucidate the mechanisms of crosstalk between lncRNAs and p53 in various cancer types.
  • To highlight the significance of lncRNA-p53 interactions in controlling cell cycle and apoptosis.

Main Methods:

  • Literature review of studies investigating p53 and lncRNA interactions in cancer.
  • Analysis of molecular mechanisms linking p53 transcriptional response to lncRNA regulation.
  • Examination of lncRNA roles in modulating p53 signaling networks.

Main Results:

  • p53 induces or suppresses lncRNAs, which in turn regulate cancer progression.
  • lncRNAs act as key regulators within the p53 signaling network, influencing global gene expression.
  • Aberrant lncRNA expression serves as a molecular-genomic signature in cancer biology.

Conclusions:

  • The crosstalk between lncRNAs and p53 is a critical determinant of cell cycle control and apoptosis in cancer.
  • Understanding these interactions is essential for developing novel cancer diagnostics and therapeutics.
  • Further research into lncRNA-p53 mechanisms can uncover new therapeutic targets for various cancers.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.2K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K